WallStreetZenWallStreetZen

NASDAQ: AARD
Aardvark Therapeutics Inc Stock Ownership - Who owns Aardvark Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aardvark Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bryan JonesChief Operating Officer2025-10-151,250$4.24
$5.30kBuy
Tienli LeeChief Executive Officer2025-10-151,229$4.24
$5.21kBuy
Tienli LeeChief Executive Officer2025-09-153,500$9.94
$34.80kBuy
Tienli LeeChief Executive Officer2025-09-156,500$9.51
$61.82kBuy
Tienli LeeChief Executive Officer2025-09-125,000$8.50
$42.52kBuy
Tienli LeeChief Executive Officer2025-09-116,000$7.82
$46.93kBuy
Tienli LeeChief Executive Officer2025-09-109,000$7.91
$71.21kBuy
Nelson SunChief Financial Officer2025-09-096,000$8.07
$48.44kBuy
Tienli LeeChief Executive Officer2025-08-2817,209$4.24
$72.97kBuy
Tienli LeeChief Executive Officer2025-02-1416,542$16.00
$264.67kBuy

1 of 2

AARD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AARD insiders and whales buy or sell their stock.

AARD Shareholders

What type of owners hold Aardvark Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital Global Life Sciences Fund IV LP18.05%3,917,299$47.01MInsider
Decheng Capital LLC18.05%3,917,299$47.01MInstitution
Tienli Lee13.91%3,018,641$36.22MInsider
Vickers Venture Fund VI Pte Ltd9.45%2,050,902$24.61MInsider
Citadel Advisors LLC5.92%1,283,732$15.40MInstitution
Laurion Capital Management LP4.56%989,068$11.87MInstitution
Cormorant Asset Management LP4.55%987,689$11.85MInsider
Cormorant Asset Management LP3.69%800,189$9.60MInstitution
Vanguard Group Inc2.12%460,977$5.53MInstitution
Silverarc Capital Management LLC1.32%286,807$3.44MInstitution

1 of 3

AARD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD41.09%47.08%Net BuyingNet Buying
ZURA45.32%54.68%Net Selling
ELDN57.27%42.73%
VYGR53.00%47.00%Net SellingNet Selling
ABEO45.24%54.76%Net SellingNet Selling
View Top Biotech Stocks

Aardvark Therapeutics Stock Ownership FAQ

Who owns Aardvark Therapeutics?

Aardvark Therapeutics (NASDAQ: AARD) is owned by 41.09% institutional shareholders, 47.08% Aardvark Therapeutics insiders, and 11.83% retail investors. Decheng Capital Global Life Sciences Fund IV LP is the largest individual Aardvark Therapeutics shareholder, owning 3.92M shares representing 18.05% of the company. Decheng Capital Global Life Sciences Fund IV LP's Aardvark Therapeutics shares are currently valued at $44.93M.

If you're new to stock investing, here's how to buy Aardvark Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.